Literature DB >> 23659780

Effect of body weight on the pharmacokinetics of flunixin meglumine in miniature horses and quarter horses.

C D Lee1, L K Maxwell.   

Abstract

In most species, large variations in body size necessitate dose adjustments based on an allometric function of body weight. Despite the substantial disparity in body size between miniature horses and light-breed horses, there are no studies investigating appropriate dosing of any veterinary drug in miniature horses. The purpose of this study was to determine whether miniature horses should receive a different dosage of flunixin meglumine than that used typically in light-breed horses. A standard dose of flunixin meglumine was administered intravenously to eight horses of each breed, and three-compartmental analysis was used to compare pharmacokinetic parameters between breed groups. The total body clearance of flunixin was 0.97 ± 0.30 mL/min/kg in miniature horses and 1.04 ± 0.27 mL/min/kg in quarter horses. There were no significant differences between miniature horses and quarter horses in total body clearance, the terminal elimination rate, area under the plasma concentration versus time curve, apparent volume of distribution at steady-state or the volume of the central compartment for flunixin (P > 0.05). Therefore, flunixin meglumine may be administered to miniature horses at the same dosage as is used in light-breed horses.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23659780     DOI: 10.1111/jvp.12056

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  1 in total

1.  Medication control of flunixin in racing horses: Possible detection times using Monte Carlo simulations.

Authors:  Taisuke Kuroda; Yohei Minamijima; Motoi Nomura; Shozo Yamashita; Masayuki Yamada; Shunichi Nagata; Hiroshi Mita; Norihisa Tamura; Kentaro Fukuda; Atsutoshi Kuwano; Kanichi Kusano; Pierre-Louis Toutain; Fumio Sato
Journal:  Equine Vet J       Date:  2021-11-25       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.